News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clinical Data To Distribute Daiichi Pure Chemicals Co. Ltd. hsCRP Assay


10/19/2005 5:13:15 PM

NEWTON, Mass.--(BUSINESS WIRE)--April 11, 2005--Clinical Data, Inc. (NASDAQ:CLDA) announced today that it has entered into a worldwide distribution agreement with Daiichi Pure Chemicals Co., Ltd., of Tokyo for a diagnostic assay for the measurement of an extended range of high sensitivity C-Reactive Protein or "hsCRP". Daiichi's proprietary assay can be used on Clinical Data's existing line of clinical chemistry analyzers and on most conventional clinical chemistry systems currently in use. The hsCRP assay, which will be distributed by Clinical Data under a non-exclusive worldwide agreement, is an in vitro diagnostic test for the quantitative determination of CRP in whole blood or serum. Measurement of CRP has been used increasingly by clinicians to aid in the detection and evaluation of infection, tissue injury, inflammatory disorders and associated diseases.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES